Here are the 424B prospectus supplements from IM Cannabis Corp. (IMCC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IMCC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMCC filings page.
IM Cannabis Corp. is offering 655,000 Common Shares at US$2.00 each to certain accredited investors in a registered direct offering. It expects net proceeds of approximately US$1.3 million for working capital and general corporate purposes, potentially including evaluation of additional opportunities. Shares outstanding were 992,494 as of September 23, 2026, and are expected to be 1,647,494 after the offering. Delivery is expected on or about September 24, 2026, subject to closing conditions.
A definitive agreement provides for Slil.com Holding Ltd. to acquire IM Cannabis’s entire interest in I.M.C. Holdings Ltd., which will hold European-focused assets after reorganization; IM Cannabis says it will retain its Israeli operations. Consideration includes a previously received CAD$3.0 million advance and Slil’s assumption of certain liabilities not materially exceeding CAD$9.4 million, subject to adjustments. Closing is conditional, and the agreement may terminate if it has not occurred by September 30, 2026. A non-binding letter of intent proposes a 51% acquisition of Space Defense Innovations and a convertible credit facility of up to EUR2.3 million. Nasdaq confirmed regained minimum bid-price compliance on September 23, 2026.